We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byVanessa Richardson
Modified over 2 years ago
Traceability in Healthcare II Vision June/July 2011
© 2008 GS1 GS1 Members Vision for Traceability in Healthcare 2 Full, End to End, actionable visibility of finished pharmaceuticals and medical devices in healthcare globally, from Point of Production 1 to Point of Use 2 All authentic items are identified with the appropriate GS1 Identification Keys (e.g. GTIN) and appropriate Application Identifier (AI, e.g. Serial No. AI(21)), if applicable, at point of production Supply chain identifiers are associated with the patient and remain with/on items throughout their intended useful life All physical locations are identified with the appropriate GS1 Identification Key (e.g. GLN) across the entire supply chain All patients and care givers, when in a care giving environment, are identified with the appropriate GS1 identification Keys Agreed master data is captured and shared (e.g. via GDSN) amongst trading partners Agreed transactional data is captured and shared (e.g. via business-to-business messaging) amongst trading partners Agreed event data is captured and shared (e.g. via EPCIS) amongst trusted traceability stakeholders, based on data sharing/security policies SO THAT: 1.The terms production or producer can also mean commercially available, manufacture(r), creation(or), compounding(er)… 2.The terms use or used can also mean consumed, infused, implanted, destroyed
© 2008 GS1 Full, End to End, actionable visibility of finished pharmaceuticals and medical devices in healthcare globally, from Point of Production 1 to Point of Use 2 SO THAT: Items can be tracked (forward / downstream) across the entire supply chain (production to use) in real time Items can be traced (backward / upstream) across the entire supply chain (from current location back to the producer) in real time Item identification is available for use at patient bedside to ensure the Patient Rights 3 are achievable Patients Electronic Health Records (EHRs) are updated with agreed traceability information, including Care Giver identification Counterfeit products are detected when entering the legitimate supply chain A product recall would be fast, efficient and effective 3 1.The terms production or producer can also mean commercially available, manufacture(r), creation(or), compounding(er)… 2.The terms use or used can also mean consumed, infused, implanted, destroyed 3.Pharmaceuticals (5): Right patient, right drug, right dose, right route, right time. Medical Devices (8): right device, right location, right time, right condition, right procedure, right anatomic site, right patient, right user GS1 Members Vision for Traceability in Healthcare
© 2008 GS1 Version Control VersionDateChange Implemented by: ChangeReason for Change Jan 09Janice KiteN/A Apr 09Janice KiteChange wording of penultimate bullet from: Counterfeit products cannot enter the legitimate supply chain without being immediately detected To: Counterfeit products are detected when entering the legitimate supply chain Increase clarity and more realistic Jun 09Janice KiteMinor editorial corrections to MissionCorrections and clarity Mar 10Janice KiteSeparate Vision on to 2 slides and add a bullet related to patient / care giver Identification Format and additional bullet Apr 10Janice KiteAdded further clarity to some bullets – i.e. added Application Identifiers to first bullet To reflect the changes identified whilst developing the GS1 Healthcare Guidance on Traceability May 10Janice KiteAdded further clarity and brevity to tag lineChanges to reflect discussions in the GS1 HC Public Policy sub-group developing Traceability White Paper June 10Janice KiteReplaced all items with finished pharmaceuticals and medical devices to tag line Discussion at Healthcare Leadership Team meeting at GS1 HC Conference in Geneva, Switzerland. Draft7 Jun 11Janice KiteAdded bullet on transactional data; added trusted to indicate that visibility of data is/can be restricted Comments from CoC/CoO (NCeP) Work Group Draft21 Jun 11Janice KiteFurther textual amendmentsBased on feedback to previous draft from TH-II & NCeP Co- Chairs. In preparation for HC LT review/approval (28 Jun 2011)
Contact Details Janice Kite Traceability Director Healthcare GS1 Global Office Avenue Louise 326, bte 10 B-1050 Brussels, Belgium T M E W
What is GS1? An Overview May © 2008 GS12 Background: What are standards? Standards are agreements that structure any activity or any industry. They.
GS1 Standards in Healthcare Nicolas Stuyckens GS1 Belgium & Luxembourg.
Traceability Lunch & Learn. Global Standards Management Process Summary Traceability today : applications and activities GTS and GS1 Traceability Solution.
GS1 Industry & Standards Event March 21-25, 2011 – Brooklyn, NY Creating value together with global standards How GSMP Technical Standards are Working.
EPCglobal HLS Industry Adoption Roadmap Final Version v13.2 Prepared by the EPCglobal HLS Industry Adoption Task Force For General Release Published ___,
GS1 Industry & Standards Event Sept 27-1 Oct 2010 – Amsterdam Creating value together with global standards Discovery Services: the Final Chapter in End-to-End.
GS1 Mobile Com Intro & Update September © 2008 GS1 How to use these slides These slides give background information and current status about the.
GS1 Industry & Standards Event March 21-25, 2011 – Brooklyn, NY Creating value together with global standards Sustainability Global Packaging Project-
Visibility and GS1 Standards. Outline Traceability and Visibility –Traceability: value-creating business processes such as recall, tracking, tracing,
GS1 EPC/RFID Technology Group Launch 9 November 2006.
GEOSS Data Sharing Principles. GEOSS 10-Year Implementation Plan 5.4 Data Sharing The societal benefits of Earth observations cannot be achieved without.
Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
Unique Device Identification (UDI) System for Medical Devices Dr Larry Kelly Therapeutic Goods Administration.
GS1 Industry & Standards Event 27 th September - 1 st October 2010 Amsterdam Hosted by Retail Value Chain IUG (RVC IUG) Plenary Session – MobileCom BNG.
1 Mary Oates, PhD Vice President, Global Quality Operations Pfizer Management of Outsourced Activities and Purchased Materials: Addressing the Interfaces.
© 2011, Data Interchange Standards Association Provider Directory Presentation to: HIT Standard Committee Privacy & Security Work Group Presented by: Don.
Privacy and Security Work Group Draft Privacy & Security Policies & Recommendations.
Data Quality Framework and Data Synchronisation. ©2008 GS1 2 Contents 1.Why Data Quality?Why Data Quality? 2.What is Data Quality?What is Data Quality?
September, 2005What IHE Delivers 1 ITI Security Profiles – ATNA, CT, EUA, PWP, DSIG IHE Vendors Workshop 2006 IHE IT Infrastructure Education Robert Horn,
Commissioning Support Lead Provider Framework Agreement Provisional statement on our approach This short discussion document aims to: Provide an update.
Lessons Learned: SPL Data Challenges within MedGuide Extraction Monday, October 28, 2013 Ed Millikan, Pharm.D. SPL Jamboree National Library of Medicine.
Data Quality Lunch and Learn Gabriel Sobrino GSMP Spring Event 2008 Brussels, Belgium.
Presenter name Presenter Organization Location and date Clinical Information Systems Adapted from Improving Chronic Illness Care
Implementing Business Driven Information Management Practices From Policy to Metadata.
LEICESTERSHIRES SHADOW HEALTH AND WELLBEING BOARD: OUR JOURNEY AND PROGRESS TO DATE January 2013 Cheryl Davenport Programme Director.
Tutorial for leadership teams of ITU-T study groups, TSAG, tariff groups and focus groups Alternative approval process (AAP) for ITU-T Recommendations.
6 th CERP Meeting One slide presentation from CERP#5 meeting 9-10 June 2008.
International Organization for Standardization TC 215 Health Informatics Audrey Dickerson, RN MS ISO/TC 215 Secretary.
1 Industry Adoption Roadmap Update Grant Hodgkins Alcon Laboratories, Inc. Former Co-Chair, EPCglobal Industry Adoption Task Force Current Co-Chair, GS1.
© 2016 SlidePlayer.com Inc. All rights reserved.